Amarin to Present at the Stifel 2020 Virtual Healthcare and Jefferies Virtual London Healthcare Conferences
November 11 2020 - 4:30PM
Amarin Corporation plc (NASDAQ:AMRN) today announced that John F.
Thero, Amarin's president and chief executive officer, is scheduled
to present general company updates at the following investor
conferences scheduled in November:
- Stifel 2020 Virtual Healthcare
conference on Monday, November 16, 2020 at 8:40 a.m. Eastern Time
(ET)
- Jefferies Virtual London Healthcare
conference on Thursday, November 19, 2020 at 9:40 a.m. Eastern Time
(ET)
Live audio webcasts of the presentations will be
available at: http://www.amarincorp.com, and will be accessible at
the same link for 30 days.
About Amarin
Amarin Corporation plc is a rapidly growing,
innovative pharmaceutical company focused on developing and
commercializing therapeutics to cost-effectively improve
cardiovascular health. Amarin’s lead product, VASCEPA® (icosapent
ethyl), is available by prescription in the United States, Canada,
Lebanon and the United Arab Emirates. VASCEPA is not yet approved
and available in any other countries. Amarin, on its own or
together with its commercial partners in select geographies, is
pursuing additional regulatory approvals for VASCEPA in China,
Europe and the Middle East. For more information about Amarin,
visit www.amarincorp.com.
Availability of Other Information About
Amarin
Investors and others should note that Amarin
communicates with its investors and the public using the company
website http://www.amarincorp.com/), the investor relations website
(http://investor.amarincorp.com/), including but not limited to
investor presentations and investor FAQs, Securities and Exchange
Commission filings, press releases, public conference calls and
webcasts. The information that Amarin posts on these channels and
websites could be deemed to be material information. As a result,
Amarin encourages investors, the media, and others interested in
Amarin to review the information that is posted on these channels,
including the investor relations website, on a regular basis. This
list of channels may be updated from time to time on Amarin’s
investor relations website and may include social media channels.
The contents of Amarin’s website or these channels, or any other
website that may be accessed from its website or these channels,
shall not be deemed incorporated by reference in any filing under
the Securities Act of 1933.
Amarin Contact Information
Investor Inquiries:Investor RelationsAmarin
Corporation plcIn U.S.: +1 (908)
719-1315investor.relations@amarincorp.com
Solebury Troutlstern@soleburytrout.comMedia
Inquiries:CommunicationsAmarin Corporation plcIn U.S.: +1 (908)
892-2028pr@amarincorp.com
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Sep 2023 to Sep 2024